4.6 Article

Tumor infiltrating M2 macrophages could predict biochemical recurrence of localized prostate cancer after radical prostatectomy

期刊

EXPERIMENTAL CELL RESEARCH
卷 384, 期 1, 页码 -

出版社

ELSEVIER INC
DOI: 10.1016/j.yexcr.2019.111588

关键词

M2 macrophages; Localized prostate cancer; Biochemical recurrence; Prognosis; CIBERSORT

资金

  1. Medical key talent of Jiangsu Province [ZDRCA2016009]
  2. National Natural Science Foundation of China [81871151,81501245,81971377]

向作者/读者索取更多资源

Given the critical role of the tumor microenvironment in PCa progression, we aimed to assess the prognostic effect of tumor infiltrating M2 macrophages (TIMMs) on biochemical recurrence (BCR) in patients with localized prostate cancer (PCa) after radical prostatectomy. A total of 127 localized PCa patients from GSE116918, 268 patients from TCGA database and 77 patients from GSE70770 were enrolled in our study. TIMMs were evaluated by the CIBERSORT method. Patients with high TIMMs had a significantly poorer recurrence free survival (RFS) (P = 0.017, P = 0.0063 and P = 0.001) in the three sets. In the multivariate analysis, the presence of high TIMMs (HR = 3.026, P = 0.023; HR = 2.679, P = 0.017; HR = 2.648, P = 0.005) was identified as an independent prognostic factor for RFS in the three sets. Harrell's Concordance index (C-index) increased in all three sets after combining TIMMs with traditional risk factors (PSA, clinical stage(T) and Gleason score). Gene Set Enrichment Analysis showed that T cell receptor signaling pathway, B cell receptor signaling pathway and primary immunodeficiency were significantly enriched in the low TIMMs group. TIMMs could serve as an independent prognostic factor for BCR in localized PCa patients after RP. Incorporation of TIMMs into traditional risk classification might further stratify patients with different prognosis.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

Decreased expression of METTL14 predicts poor prognosis and construction of a prognostic signature for clear cell renal cell carcinoma

Yi Wang, Rong Cong, Shouyong Liu, Bingye Zhu, Xing Wang, Qianwei Xing

Summary: Our study demonstrated that METTL14 could serve as a favorable prognostic factor in clear cell renal cell carcinoma (ccRCC), being associated with better overall survival. Additionally, significant enrichment of METTL14 in multiple signaling pathways was identified, and a prognostic signature integrating METTL14 expression and clinicopathologic variables was established to predict survival probabilities in ccRCC. Furthermore, a METTL14-based risk score was developed with improved prognostic accuracy.

CANCER CELL INTERNATIONAL (2021)

Article Oncology

High expression of CDCA7 predicts poor prognosis for clear cell renal cell carcinoma and explores its associations with immunity

Shouyong Liu, Yi Wang, Chenkui Miao, Qianwei Xing, Zengjun Wang

Summary: CDCA7 is overexpressed in ccRCC and associated with shorter overall survival. It is identified as an independent prognostic factor and closely related to microsatellite instability, tumor mutational burden, and immunity.

CANCER CELL INTERNATIONAL (2021)

Article Cell Biology

A Candidate Prognostic Biomarker Complement Factor I Promotes Malignant Progression in Glioma

Xiaomin Cai, Wenjin Qiu, Mengshu Qian, Shuang Feng, Chenghao Peng, Jiale Zhang, Yi Wang, Yuhai Wang

Summary: CFI is overexpressed in glioma and is associated with poor outcomes, serving as a potential prognostic biomarker and driving malignant progression in glioma.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Article Biochemistry & Molecular Biology

A Novel Nine Apoptosis-Related Genes Signature Predicting Overall Survival for Kidney Renal Clear Cell Carcinoma and its Associations with Immune Infiltration

Yi Wang, Yinhao Chen, Bingye Zhu, Limin Ma, Qianwei Xing

Summary: This study established and validated a prognostic model for predicting overall survival in ccRCC patients based on apoptosis-related genes, providing clinicians with a standardized tool for prognostic assessment. Future prospective studies are needed to further validate these findings.

FRONTIERS IN MOLECULAR BIOSCIENCES (2021)

Article Oncology

A novel 10 glycolysis-related genes signature could predict overall survival for clear cell renal cell carcinoma

Qianwei Xing, Tengyue Zeng, Shouyong Liu, Hong Cheng, Limin Ma, Yi Wang

Summary: A novel signature based on 10 prognostic GRGs was successfully established and externally and internally validated for predicting OS of ccRCC, assisting clinicians in better predicting patients' survival.

BMC CANCER (2021)

Article Cell Biology

Ferroptosis-related gene CHAC1 is a valid indicator for the poor prognosis of kidney renal clear cell carcinoma

Deng Li, Shiwei Liu, Jie Xu, Lei Chen, Chaoliang Xu, Feiteng Chen, Zijie Xu, Yu Zhang, Shujie Xia, Yi Shao, Yi Wang

Summary: Through bioinformatic analyses, it was found that CHAC1 has the potential to predict malignancy and prognosis in KIRC. Various analyses confirmed that up-regulated CHAC1 is an independent risk factor for poor prognosis in KIRC, and a model was constructed to predict patient survival rates. CHAC1 was also found to be associated with immune pathway markers and checkpoint genes.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)

Article Medicine, Research & Experimental

Six RNA binding proteins (RBPs) related prognostic model predicts overall survival for clear cell renal cell carcinoma and is associated with immune infiltration

Qianwei Xing, Jiaochen Luan, Shouyong Liu, Limin Ma, Yi Wang

Summary: The aim of this article was to construct a prognostic model using RNA-binding proteins (RBPs) to predict overall survival for patients with clear cell renal cell carcinoma (ccRCC), as well as explore its associations with immune infiltration. The study successfully identified six RBPs as a robust prognostic signature, which was strongly related to ccRCC patients' survival and clinicopathological characteristics. The established model also displayed significant associations with immune infiltration.

BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES (2022)

Article Pathology

A novel 13 RNA binding proteins (RBPs) signature could predict prostate cancer biochemical recurrence

Qianwei Xing, Shouyong Liu, Jiaochen Luan, Yi Wang, Limin Ma

Summary: This study established a model for predicting BCR in prostate cancer patients using RBPs, demonstrating its predictive performance and the importance of being an independent prognostic factor. External and internal verification showed that patients with high riskScores had shorter time to BCR.

PATHOLOGY RESEARCH AND PRACTICE (2021)

Article Oncology

Increased CDC6 Expression Associates With Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma

Yicong Yao, Yi Wang, Denglong Wu, Baoying Hu

Summary: The increased expression of CDC6 is potentially a poor prognostic factor in ccRCC patients. High CDC6 expression is correlated with malignant characteristics of tumors and multiple signaling pathways, as well as with immune-related factors, tumor microenvironment, and immune cell infiltration. The results from the TCGA database also show a significant relationship between CDC6 and immune checkpoint molecules and immune cells.

FRONTIERS IN ONCOLOGY (2021)

Article Cell Biology

Bortezomib alleviates antibody-mediated rejection in kidney transplantation by facilitating Atg5 expression

Hong Cheng, Bin Xu, Lijie Zhang, Yi Wang, Ming Chen, Shuqiu Chen

Summary: The study demonstrated that bortezomib could reduce the levels of donor-specific antibodies, alleviate inflammation in grafts, modulate immune cell ratios, and affect cytokine expression to slow down the rejection process. By targeting Atg5, bortezomib may play a key role in attenuating antibody-mediated rejection.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)

Article Immunology

Molecular subtypes based on metabolic genes are potential biomarkers for predicting prognosis and immune responses of clear cell renal cell carcinoma

Yi Wang, Hao Ji, Bingye Zhu, Qianwei Xing, Huyang Xie

Summary: Due to tumor molecular heterogeneity, similar ccRCC patients may have different survival rates. This study identified three metabolic subtypes of ccRCC based on novel metabolism-associated genes (MAGs) and explored their association with immune landscapes and prognosis. The results showed that these subtypes were associated with various immune markers and could predict immunotherapeutic responses.

EUROPEAN JOURNAL OF IMMUNOLOGY (2023)

Article Biotechnology & Applied Microbiology

USP31 serves as a potential biomarker for predicting prognosis and immune responses for clear cell renal cell carcinoma via single-cell and bulk RNA-sequencing

Yaoyu Yu, Guihua Chen, Chao Jiang, Tuanjie Guo, Heting Tang, Zhihao Yuan, Yi Wang, Xiangyin Tan, Jinyuan Chen, Encheng Zhang, Xiang Wang

Summary: This study used bioinformatics analysis to confirm that the high expression of USP31 in clear cell renal cell carcinoma is associated with poor prognosis, and found that USP31 may be related to immunity and can serve as a potential biomarker for predicting prognosis and immune response in kidney cancer patients.

JOURNAL OF GENE MEDICINE (2023)

Article Multidisciplinary Sciences

Identification and validation of molecular subtypes' characteristics in bladder urothelial carcinoma based on autophagy-dependent ferroptosis

Shiwei Liu, Jing Zhai, Deng Li, Yu Peng, Yi Wang, Bo Dai

Summary: This study established a prognostic signature of autophagy-dependent ferroptosis regulatory molecules (ADFRMs) in bladder urothelial carcinoma (BLCA) and identified TRIB3 and WIPI1 as potential prognostic genes. The ADFRMs signature showed an acceptable capacity for survival prediction in BLCA.

HELIYON (2023)

Article Genetics & Heredity

Integrated analyses reveal the prognostic, immunological features and mechanisms of cuproptosis critical mediator gene FDX1 in KIRC

Yi Wang, Xinyu Zhang, Guihua Chen, Qianwei Xing, Bingye Zhu, Xiang Wang

Summary: This study aimed to explore the roles of FDX1 in kidney renal clear cell carcinoma (KIRC) and its potential molecular mechanisms using scRNA-sequencing and bulk RNA-sequencing analyses. FDX1 was found to be lowly expressed in KIRC and its elevated expression was associated with better overall survival prognosis. Gene set enrichment analysis identified seven pathways strongly associated with FDX1 in KIRC. Furthermore, FDX1 was significantly related to immunity and patients with low expression of FDX1 might be more sensitive to immunotherapies.

GENES AND IMMUNITY (2023)

Article Biotechnology & Applied Microbiology

Nucleolar protein NOP2 could serve as a potential prognostic predictor for clear cell renal cell carcinoma

Gang Wang, Fangfang Qu, Shouyong Liu, Jincai Zhou, Yi Wang

Summary: This study revealed that NOP2 might be a potential prognostic factor for overall survival in ccRCC, and it was significantly associated with immunity, MSI, and TMB.

BIOENGINEERED (2021)

暂无数据